| scholarly article | Q13442814 |
| P50 | author | Susan Lynch | Q89867375 |
| Rashida Ferrand | Q21264543 | ||
| P2093 | author name string | Laurence Huang | |
| John Z Metcalfe | |||
| Douglas W Fadrosh | |||
| Grace McHugh | |||
| Sudha Bhadriraju | |||
| Din L Lin | |||
| Kathryn McCauley | |||
| Meera K Shenoy | |||
| Edith D Majonga | |||
| Kole V Lynch | |||
| P2860 | cites work | Reagent and laboratory contamination can critically impact sequence-based microbiome analyses | Q21146690 |
| The Interplay Between Immune Response and Bacterial Infection in COPD: Focus Upon Non-typeable | Q59130095 | ||
| Alterations in Oral Microbiota in HIV Are Related to Decreased Pulmonary Function | Q91088402 | ||
| Distinct nasal airway bacterial microbiotas differentially relate to exacerbation in pediatric patients with asthma | Q92765247 | ||
| Alterations in the oral microbiome in HIV-infected participants after antiretroviral therapy administration are influenced by immune status | Q95805613 | ||
| Disordered microbial communities in asthmatic airways | Q21562589 | ||
| Dual Role of Toll-Like Receptors in Asthma and Chronic Obstructive Pulmonary Disease | Q27014653 | ||
| Standardisation of spirometry | Q29547365 | ||
| Moraxella catarrhalis: from Emerging to Established Pathogen | Q33906182 | ||
| Interleukin 8 and Acute Lung Injury | Q34351933 | ||
| Topographical continuity of bacterial populations in the healthy human respiratory tract | Q35528519 | ||
| The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development | Q35599871 | ||
| Influence and effect of the human microbiome in allergy and asthma | Q35639786 | ||
| The airway microbiome in patients with severe asthma: Associations with disease features and severity. | Q35721479 | ||
| Interleukin-1β regulates CXCL8 release and influences disease outcome in response to Streptococcus pneumoniae, defining intercellular cooperation between pulmonary epithelial cells and macrophages | Q35805458 | ||
| Correlation of the lung microbiota with metabolic profiles in bronchoalveolar lavage fluid in HIV infection | Q35899601 | ||
| Analysis of Lung Microbiota in Bronchoalveolar Lavage, Protected Brush and Sputum Samples from Subjects with Mild-To-Moderate Cystic Fibrosis Lung Disease | Q35946121 | ||
| HIV status, burden of comorbid disease, and biomarkers of inflammation, altered coagulation, and monocyte activation | Q36383621 | ||
| Comparison of the respiratory microbiome in healthy nonsmokers and smokers | Q37073006 | ||
| Effect of Advanced HIV Infection on the Respiratory Microbiome | Q37213594 | ||
| Enrichment of the lung microbiome with oral taxa is associated with lung inflammation of a Th17 phenotype. | Q37229478 | ||
| Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. | Q37317826 | ||
| Moraxella Catarrhalis: An Unrecognized Pathogen of the Oral Cavity? | Q37785087 | ||
| Incidence of opportunistic and other infections in HIV-infected children in the HAART era. | Q38467275 | ||
| The Lung Immune Response to Nontypeable Haemophilus influenzae (Lung Immunity to NTHi). | Q38538384 | ||
| Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment | Q38795934 | ||
| Immune Response and Mortality Risk Relate to Distinct Lung Microbiomes in Patients with HIV and Pneumonia | Q38853678 | ||
| Bronchiectasis and other chronic lung diseases in adolescents living with HIV. | Q38883323 | ||
| Airway Microbiota and the Implications of Dysbiosis in Asthma | Q38890722 | ||
| Host-pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen | Q38923632 | ||
| Chronic lung disease in HIV-infected children established on antiretroviral therapy. | Q39415988 | ||
| Moraxella catarrhalis is internalized in respiratory epithelial cells by a trigger-like mechanism and initiates a TLR2- and partly NOD1-dependent inflammatory immune response | Q40217556 | ||
| Lung epithelium is the major source of IL-33 and is regulated by IL-33-dependent and IL-33-independent mechanisms in pulmonary cryptococcosis | Q40551299 | ||
| C-Mannosylation of MUC5AC and MUC5B Cys subdomains | Q40600264 | ||
| HIV-Associated Chronic Lung Disease in Children and Adolescents in Zimbabwe: Chest Radiographic and High-Resolution Computed Tomography Findings | Q41919105 | ||
| Compositionally and functionally distinct sinus microbiota in chronic rhinosinusitis patients have immunological and clinically divergent consequences | Q41993348 | ||
| The Moraxella catarrhalis-induced pro-inflammatory immune response is enhanced by the activation of the epidermal growth factor receptor in human pulmonary epithelial cells. | Q42208278 | ||
| The Role of Transforming Growth Factor Beta-1 in the Progression of HIV/AIDS and Development of Non-AIDS-Defining Fibrotic Disorders | Q45783074 | ||
| Molecular Aspects of Moraxella catarrhalis Pathogenesis | Q45849277 | ||
| Dynamics of bacterial colonization with Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis during symptomatic and asymptomatic viral upper respiratory infection | Q46168497 | ||
| Role of the lung microbiome in HIV pathogenesis | Q46189253 | ||
| Comparison of Whole and Acellular Bronchoalveolar Lavage to Oral Wash Microbiomes. Should Acellular Bronchoalveolar Lavage Be the Standard? | Q46275891 | ||
| The CF-Sputum Induction Trial (CF-SpIT) to assess lower airway bacterial sampling in young children with cystic fibrosis: a prospective internally controlled interventional trial. | Q54205691 | ||
| P433 | issue | 1 | |
| P921 | main subject | lung disease | Q3392853 |
| P304 | page(s) | 16186 | |
| P577 | publication date | 2020-09-30 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Distinct lung microbiota associate with HIV-associated chronic lung disease in children | |
| P478 | volume | 10 |
Search more.